These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7866474)

  • 21. Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.
    Jain AK; Kaplan RA; Gadde KM; Wadden TA; Allison DB; Brewer ER; Leadbetter RA; Richard N; Haight B; Jamerson BD; Buaron KS; Metz A
    Obes Res; 2002 Oct; 10(10):1049-56. PubMed ID: 12376586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of phenylpropanolamine in the management of moderate obesity.
    Schteingart DE
    Int J Obes Relat Metab Disord; 1992 Jul; 16(7):487-93. PubMed ID: 1323545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men.
    Lejeune MP; Hukshorn CJ; Saris WH; Westerterp-Plantenga MS
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1494-9. PubMed ID: 14634680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoxetine treatment of the obese diabetic.
    Gray DS; Fujioka K; Devine W; Bray GA
    Int J Obes Relat Metab Disord; 1992 Mar; 16(3):193-8. PubMed ID: 1317828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variables predictive of adherence to diet and physical activity recommendations in the treatment of obesity and overweight, in a group of Spanish subjects.
    Bautista-Castaño I; Molina-Cabrillana J; Montoya-Alonso JA; Serra-Majem L
    Int J Obes Relat Metab Disord; 2004 May; 28(5):697-705. PubMed ID: 14993911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: a randomized clinical trial.
    Andersen T; Astrup A; Quaade F
    Int J Obes Relat Metab Disord; 1992 Jan; 16(1):35-40. PubMed ID: 1314242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does sibutramine keep the weight off?
    Maughan KL
    J Fam Pract; 1999 Jun; 48(6):420. PubMed ID: 10386483
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects.
    Astrup A; Caterson I; Zelissen P; Guy-Grand B; Carruba M; Levy B; Sun X; Fitchet M
    Obes Res; 2004 Oct; 12(10):1658-69. PubMed ID: 15536230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
    Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet.
    Munro IA; Garg ML
    Br J Nutr; 2012 Oct; 108(8):1466-74. PubMed ID: 22214842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.
    Ryttig KR; Tellnes G; Haegh L; Bøe E; Fagerthun H
    Int J Obes; 1989; 13(2):165-71. PubMed ID: 2545640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
    Gadde KM; Yonish GM; Wagner HR; Foust MS; Allison DB
    Int J Obes (Lond); 2006 Jul; 30(7):1138-42. PubMed ID: 16418753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial.
    Auvichayapat P; Prapochanung M; Tunkamnerdthai O; Sripanidkulchai BO; Auvichayapat N; Thinkhamrop B; Kunhasura S; Wongpratoom S; Sinawat S; Hongprapas P
    Physiol Behav; 2008 Feb; 93(3):486-91. PubMed ID: 18006026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic markers for diet-induced weight loss in obese women.
    Astrup A; Buemann B; Gluud C; Bennett P; Tjur T; Christensen N
    Int J Obes Relat Metab Disord; 1995 Apr; 19(4):275-8. PubMed ID: 7627252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults.
    Mhurchu CN; Poppitt SD; McGill AT; Leahy FE; Bennett DA; Lin RB; Ormrod D; Ward L; Strik C; Rodgers A
    Int J Obes Relat Metab Disord; 2004 Sep; 28(9):1149-56. PubMed ID: 15311218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.